Compare T-Rex 2X Inverse MSTR Daily Target ETF (MSTZ) vs Revvity Inc (RVTY) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
T-Rex 2X Inverse MSTR Daily Target ETF vs Revvity Inc — how do they compare? T-Rex 2X Inverse MSTR Daily Target ETF trades at $10.57, while Revvity Inc trades at $110.7 (market cap $11.87B). The key difference: Revvity Inc pays a 0.26% dividend while T-Rex 2X Inverse MSTR Daily Target ETF pays none, and Revvity Inc is trading nearer its 52-week high, T-Rex 2X Inverse MSTR Daily Target ETF nearer its low. Which is the better fit depends on your goals.
| MSTZ | RVTY | |
|---|---|---|
Sector | Leveraged / Inverse | Technology |
52-Week High | $27.92 | $117.75 |
52-Week Low | $3.50 | $82.26 |
Market Cap | — | $11.87B |
Enterprise Value | — | $14.36B |
Dividend Yield | — | 0.26% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About T-Rex 2X Inverse MSTR Daily Target ETF
MSTZ is a leveraged ETF that seeks daily investment results corresponding to 200% of the inverse (opposite) of the daily performance of the MicroStrategy Incorporated (MSTR) stock. It is designed as a tactical tool for experienced traders to take a bearish position on MSTR, a company known for its large Bitcoin holdings. Due to the effects of compounding and leverage, the ETF is intended to be held for a single day and is not suitable for long-term investment, as its performance over longer periods may significantly deviate from its stated daily objective.
Read more on MSTZ →About Revvity Inc
Revvity, Inc., formerly the Life Sciences and Diagnostics businesses of PerkinElmer, is a global provider of scientific and diagnostic solutions. The company focuses on the health and wellness of humanity through its expertise in life science research, detection, imaging, and informatics. Revvity supplies a broad portfolio of instruments, reagents, and services to pharmaceutical companies, academic research institutions, and clinical laboratories worldwide, enabling customers to make advancements in human health.
Read more on RVTY →
